Jacek Polosak

Jacek Polosak

Auto-generated profile, based on publicly available information

Jacek Polosak

Department of Biochemistry and Molecular Biology, Medical Center of Postgraduate Education, Warsaw, Poland

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2016 in International Journal of Obesity
Verified
Journal Article
Closed access
Alina KurylowiczAlina Kurylowicz
Alina Kurylowicz
MOM Owczarz
M Owczarz
JPJ Polosak
J Polosak
MJM I Jonas
M I Jonas
Wojciech LisikWojciech Lisik
Wojciech Lisik
MPMonika Puzianowska-Kuznicka
Monika Puzianowska-Kuznicka

12 July 2017 in Experimental Biology and Medicine
Verified
Journal Article
Closed access
MOMagdalena Owczarz
Magdalena Owczarz
MBMonika Budzinska
Monika Budzinska
ADAnna Paulina Domaszewska-Szostek
Anna Paulina Domaszewska-Szostek
JBJoanna Borkowska
Joanna Borkowska
JPJacek Polosak
Jacek Polosak
MPMonika Puzianowska-Kuznicka
Monika Puzianowska-Kuznicka
High expression of sirtuins, particularly SIRT1, lowers the risk of age-related diseases and probably slows down the rate of aging; therefore, their sustained expression should be one of the features of longevity. However, in this work we show that in peripheral blood mononuclear cells (PBMC) of long-lived individuals, expression of majority of the SIRT genes is significantly lower than in cells of young study subjects. In long-lived individuals, downregulation of SIRT1 coexists with upregulation of SIRT1 mRNA-interacting miR-34a and miR-9, indicating the role of epigenetic drift in age-dependent deregulation of SIRT1 expression. Such constellation of SIRT1, miR-34a, and miR-9 expression in PBMC of successfully aging long-lived individuals indicates that, at least in these individuals, it is not a risk factor for morbidity and mortality. It might however affect the function of the immune system and, therefore, aging individuals can profit from interventions increasing the level of SIRT1.

19 February 2014 in Endokrynologia Polska
Verified
Journal Article
Open access
PDF file
MRMałgorzata Roszkowska-Gancarz
Małgorzata Roszkowska-Gancarz
AKAlina Kurylowicz
Alina Kurylowicz
JPJacek Polosak
Jacek Polosak
MMMałgorzata Mossakowska
Małgorzata Mossakowska
EFEdward Franek
Edward Franek
MPMonika Puzianowska-Kuznicka
Monika Puzianowska-Kuznicka
Introduction: Longevity is commonly associated with good health and with delayed onset of age-related diseases with usually benign course. Leptin (LEP) significantly affects metabolism and numerous functions of the organism. To find out if extreme longevity and its phenotype are associated with genetic variants of leptin and leptin receptor (LEPR) genes, we analysed the frequencies of the –2548 G/A and +19 G/A LEP, as well as the K109R, Q223R, and K656N LEPR polymorphisms in centenarians and in control groups. Material and methods: The frequencies of the LEP and LEPR polymorphisms were tested by restriction fragment length polymorphism in 128 centenarians, 414 young controls (Y), 226 myocardial infarction (MI) patients, and 190 type 2 diabetes mellitus (DM2) patients. Results: The GG genotype of the –2548 G/A LEP polymorphism was significantly more common in centenarians than in the Y, MI and DM2 groups (p = 0.048, p = 0.003, p = 0.049, respectively). In addition, the AA genotype of the K109R LEPR polymorphism was significantly less frequent in centenarians than in the Y, MI, and DM2 groups (p = 0.026, p = 0.013, and p = 0.001, respectively). Conclusions: We suggest that the leptin pathway plays a role in the regulation of longevity, possibly by modulating the risk of development of MI and of DM2. (Endokrynol Pol 2014; 65 (1): 11–16) Introduction: Longevity is commonly associated with good health and with delayed onset of age-related diseases with usually benign course. Leptin (LEP) significantly affects metabolism and numerous functions of the organism. To find out if extreme longevity and its phenotype are associated with genetic variants of leptin and leptin receptor (LEPR) genes, we analysed the frequencies of the –2548 G/A and +19 G/A LEP, as well as the K109R, Q223R, and K656N LEPR polymorphisms in centenarians and in control groups. Material and methods: The frequencies of the LEP and LEPR polymorphisms were tested by restriction fragment length polymorphism in 128 centenarians, 414 young controls (Y), 226 myocardial infarction (MI) patients, and 190 type 2 diabetes mellitus (DM2) patients. Results: The GG genotype of the –2548 G/A LEP polymorphism was significantly more common in centenarians than in the Y, MI and DM2 groups (p = 0.048, p = 0.003, p = 0.049, respectively). In addition, the AA genotype of the K109R LEPR polymorphism was significantly less frequent in centenarians than in the Y, MI, and DM2 groups (p = 0.026, p = 0.013, and p = 0.001, respectively). Conclusions: We suggest that the leptin pathway plays a role in the regulation of longevity, possibly by modulating the risk of development of MI and of DM2. (Endokrynol Pol 2014; 65 (1): 11–16)

26 February 2014 in Geriatrics & Gerontology International
Verified
Journal Article
Closed access
PDF file
MRMalgorzata Roszkowska‐Gancarz
Malgorzata Roszkowska‐Gancarz
MJMarta Jonas
Marta Jonas
MOMagdalena Owczarz
Magdalena Owczarz
AKAlina Kurylowicz
Alina Kurylowicz
JPJacek Polosak
Jacek Polosak
MPMonika Puzianowska-Kuznicka
Monika Puzianowska-Kuznicka

28 February 2013 in International Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
MPMonika Puzianowska-Kuznicka
Monika Puzianowska-Kuznicka
EPEliza Pawlik-Pachucka
Eliza Pawlik-Pachucka
MOMagdalena Owczarz
Magdalena Owczarz
MBMonika Budzińska
Monika Budzińska
JPJacek Polosak
Jacek Polosak
Small-molecule hormones play crucial roles in the development and in the maintenance of an adult mammalian organism. On the molecular level, they regulate a plethora of biological pathways. Part of their actions depends on their transcription-regulating properties, exerted by highly specific nuclear receptors which are hormone-dependent transcription factors. Nuclear hormone receptors interact with coactivators, corepressors, basal transcription factors, and other transcription factors in order to modulate the activity of target genes in a manner that is dependent on tissue, age and developmental and pathophysiological states. The biological effect of this mechanism becomes apparent not earlier than 30–60 minutes after hormonal stimulus. In addition, small-molecule hormones modify the function of the cell by a number of nongenomic mechanisms, involving interaction with proteins localized in the plasma membrane, in the cytoplasm, as well as with proteins localized in other cellular membranes and in nonnuclear cellular compartments. The identity of such proteins is still under investigation; however, it seems that extranuclear fractions of nuclear hormone receptors commonly serve this function. A direct interaction of small-molecule hormones with membrane phospholipids and with mRNA is also postulated. In these mechanisms, the reaction to hormonal stimulus appears within seconds or minutes.

26 August 2009 in Biogerontology
Verified
Journal Article
Closed access
PDF file
JPJacek Polosak
Jacek Polosak
MRMalgorzata Roszkowska-Gancarz
Malgorzata Roszkowska-Gancarz
Alina KurylowiczAlina Kurylowicz
Alina Kurylowicz
MOMagdalena Owczarz
Magdalena Owczarz
PDPaula Dobosz
Paula Dobosz
MPMonika Puzianowska-Kuznicka
Monika Puzianowska-Kuznicka